🇺🇸 FDA
Patent

US 9469683

Lysosomal targeting peptides and uses thereof

granted A61KA61K38/47A61P

Quick answer

US patent 9469683 (Lysosomal targeting peptides and uses thereof) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOMARIN PHARMACEUTICAL INC.
Grant date
Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K38/47, A61P, A61P3/00, A61P43/00